Combination Treatment With Doxorubicin and microRNA-21 Inhibitor Synergistically Augments Anticancer Activity Through Upregulation of Tumor Suppressing Genes

International Journal of Oncology - Greece
doi 10.3892/ijo.2015.2841
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The Multi-Kinase Inhibitor Ec-70124 Synergistically Increased the Anti-Tumor Activity of Doxorubicin in Sarcomas

International Journal of Cancer
Cancer ResearchOncology
2019English

Anti-Tumor Activity of Selective Inhibitor of Nuclear Export (SINE) Compounds, Is Enhanced in Non-Hodgkin Lymphoma Through Combination With mTOR Inhibitor and Dexamethasone

Cancer Letters
Cancer ResearchOncology
2016English

Incorporation of Doxorubicin in Different Polymer Nanoparticles and Their Anticancer Activity

Beilstein Journal of Nanotechnology
Electronic EngineeringMaterials ScienceNanoscienceElectricalNanotechnologyAstronomyPhysics
2019English

The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

574. Combination Anticancer Therapy of Doxorubicin and siRNA by Acid-Labile Polymer-Based Cationic Liposomes

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Doxorubicin Induces Cardiotoxicity Through Upregulation of Death Receptors Mediated Apoptosis in Cardiomyocytes

Scientific Reports
Multidisciplinary
2017English

Identification of microRNA-21 Target Genes Associated With Hair Follicle Development in Sheep

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Anticancer Opportunity Created by Loss of Tumor Suppressor Genes

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2016English

Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway

Frontiers in Oncology
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy